These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 27385349)

  • 1. Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Healive® and Havrix® among children: A 5-year follow-up study.
    Yu C; Song Y; Qi Y; Li C; Jiang Z; Li C; Zhang W; Wang L; Xia J
    Hum Vaccin Immunother; 2016 Oct; 12(10):2595-2602. PubMed ID: 27385349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunogenicity persistence of hepatitis A vaccines Healive® and Havrix® among children:15 years follow-up and long-term prediction.
    Wang X; Xu W; Hu Y; Yao H; Xu L; Ma M; Zhang Y; Wang Y
    Hum Vaccin Immunother; 2023 Aug; 19(2):2227549. PubMed ID: 37357804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of immunogenicity between inactivated and live attenuated hepatitis A vaccines: a single-blind, randomized, parallel-group clinical trial among children in Xinjiang Uighur Autonomous Region, China.
    Liu XE; Wushouer F; Gou A; Kuerban M; Li X; Sun Y; Zhang J; Liu Y; Li J; Zhuang H
    Hum Vaccin Immunother; 2013 Jul; 9(7):1460-5. PubMed ID: 23571173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity persistence in children of hepatitis A vaccines Healive® and Havrix®: 11 years follow-up and long-term prediction.
    Wang Y; Qi Y; Xu W; Hu Y; Wang L; Yu Y; Jiang Z; Xia J; Zeng G; Wang Y
    Hum Vaccin Immunother; 2020 Oct; 16(10):2559-2564. PubMed ID: 32040376
    [No Abstract]   [Full Text] [Related]  

  • 5. Interchangeability and tolerability of two inactivated hepatitis A vaccines in Chinese children.
    Zhang ZL; Zhu XJ; Wang X; Liang M; Sun J; Liu Y; Gao ZG; Wu JY; Dong XJ; Liu RK; Chen JT; Zhang YQ; Wang W; Zhang LP; Yin W
    Vaccine; 2012 Jun; 30(27):4028-33. PubMed ID: 22537990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immune persistence among inactivated and live attenuated hepatitis a vaccines 2 years after a single dose.
    Zhang X; An J; Tu A; Liang X; Cui F; Zheng H; Tang Y; Liu J; Wang X; Zhang N; Li H
    Hum Vaccin Immunother; 2016 Sep; 12(9):2322-6. PubMed ID: 27494260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing live attenuated and inactivated hepatitis A vaccines: an immunogenicity study after one single dose.
    Zheng H; Chen Y; Wang F; Gong X; Wu Z; Miao N; Zhang X; Li H; Chen C; Hou X; Cui F; Wang H
    Vaccine; 2011 Nov; 29(48):9098-103. PubMed ID: 21875638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
    Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
    Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term Serologic Follow-up of Children Vaccinated with a Pediatric Formulation of Virosomal Hepatitis A Vaccine Administered With Routine Childhood Vaccines at 12-15 Months of Age.
    Dagan R; Ashkenazi S; Livni G; Go O; Bagchi P; Sarnecki M
    Pediatr Infect Dis J; 2016 Jul; 35(7):e220-8. PubMed ID: 27093164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A single blind randomized phase 3 study to evaluate safety and immunogenicity of inactivated hepatitis A vaccine (HAPIBEV
    Thuluva S; Matur R; Tsa K; Gv SR
    Vaccine; 2021 Dec; 39(49):7166-7174. PubMed ID: 34763950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity and safety of a pediatric dose of a virosomal hepatitis A vaccine in healthy children in India.
    Jain H; Kumavat V; Singh T; Versteilen A; Sarnecki M
    Hum Vaccin Immunother; 2014; 10(7):2089-97. PubMed ID: 25424821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling the Long-term Antibody Response and Duration of Immune Protection Induced by an Inactivated, Preservative-free Hepatitis A Vaccine (Healive) in Children.
    Yu YP; Chen JT; Jiang ZW; Wang L; Yu CK; Yan XY; Yao C; Xia JL
    Biomed Environ Sci; 2020 Jul; 33(7):484-492. PubMed ID: 32807267
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the safety and immunogenicity of live attenuated and inactivated hepatitis A vaccine in healthy Chinese children aged 18 months to 16 years: results from a randomized, parallel controlled, phase IV study.
    Ma F; Yang J; Kang G; Sun Q; Lu P; Zhao Y; Wang Z; Luo J; Wang Z
    Clin Microbiol Infect; 2016 Sep; 22(9):811.e9-811.e15. PubMed ID: 27345175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An open, prospective, randomized study comparing the immunogenicity and safety of two inactivated hepatitis A pediatric vaccines in toddlers, children and adolescents in China.
    Li RC; Li Y; Yi N; Huang L; Wan Z; Zhang Y; Rasuli A
    Pediatr Infect Dis J; 2013 Feb; 32(2):e77-81. PubMed ID: 23334341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reappraisal of the Immunogenicity and Safety of Three Hepatitis A Vaccines in Adolescents.
    Yoon SH; Kim HW; Ahn JG; Kim IT; Kim JH; Kong KA; Kim KH
    J Korean Med Sci; 2016 Jan; 31(1):73-9. PubMed ID: 26770041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term antibody persistence after vaccination with a 2-dose Havrix (inactivated hepatitis A vaccine): 20 years of observed data, and long-term model-based predictions.
    Theeten H; Van Herck K; Van Der Meeren O; Crasta P; Van Damme P; Hens N
    Vaccine; 2015 Oct; 33(42):5723-5727. PubMed ID: 26190091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of an inactivated hepatitis A pediatric vaccine: three-year post-booster follow-up.
    Dagan R; Greenberg D; Weber F
    Vaccine; 2005 Oct; 23(44):5144-8. PubMed ID: 16043271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of hepatitis A vaccine in children with celiac disease.
    Sari S; Dalgic B; Basturk B; Gonen S; Soylemezoglu O
    J Pediatr Gastroenterol Nutr; 2011 Nov; 53(5):532-5. PubMed ID: 21587080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.